Drug intelligence / Profile preview

elaeagnus angustifolia

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical, Dietary
01

Overview

Elaeagnus angustifolia is a medicinal plant widely known as **Russian olive** or **oleaster**, traditionally used in various systems of herbal medicine. The plant's main pharmacologically active components are flavonoids, anthocyanins, saponins, terpenoids, and alkaloids. Extracts, especially from the fruit and seeds, demonstrate significant analgesic, anti-inflammatory, anti-ulcer, antioxidant, wound healing, and antimicrobial activities. Mechanistically, flavonoids in E. angustifolia inhibit cyclooxygenase (COX) and lipooxygenase enzymes, block bradykinin and arachidonic acid pathways, modulate NMDA receptor activity, and reduce inflammation through NF-κB pathway inhibition. The alkaloids harman and harmaline inhibit monoamine oxidase (MAO), increasing serotonin and noradrenaline levels. Clinically, extracts have shown efficacy in relieving chronic pain (notably knee osteoarthritis), accelerating wound healing, exhibiting gastroprotective actions (reducing gastric acid secretion and oxidative mucosal injury), and exerting antineoplastic effects likely via immune activation and anti-angiogenesis. Topical, oral, and dietary uses are reported across traditional and modern studies[1][2][3].

Other names
russian oliveoleastersenjed
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NMDAR (Glutamate receptor ionotropic, NMDA)PGHS-1 (Prostaglandin G/H Synthase 1)NF-κBMAOA (Monoamine oxidase A)

Beyond the preview

Go deeper on elaeagnus angustifolia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on elaeagnus angustifolia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call